Literature DB >> 4626169

Renal contribution to overall metabolism of drugs. II. Biotransformation of salicylic acid to salicyluric acid.

S H Wan, S Riegelman.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1972        PMID： 4626169     DOI： 10.1002/jps.2600610823

Source DB:  PubMed          Journal:  J Pharm Sci        ISSN： 0022-3549            Impact factor:   3.534


× No keyword cloud information.
  9 in total

1.  The role of the kidney in the elimination of cephapirin in man.

Authors:  B E Cabana; D R Van Harken; G H Hottendorf; J T Doluisio; W O Griffen; D W Bourne; L W Dittert
Journal:  J Pharmacokinet Biopharm       Date:  1975-12

2.  Effect of substituted benzoates on p-aminohippurate transport in dog renal membrane vesicles.

Authors:  F G Russel; M Heijn; R C de Laet; C A van Ginneken
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1991-01       Impact factor: 3.000

3.  Comparative pharmacokinetics and metabolism of cephapirin in laboratory animals and humans.

Authors:  B E Cabana; D R van Harken; G H Hottendorf
Journal:  Antimicrob Agents Chemother       Date:  1976-08       Impact factor: 5.191

Review 4.  Drug interactions at the renal level. Implications for drug development.

Authors:  P L Bonate; K Reith; S Weir
Journal:  Clin Pharmacokinet       Date:  1998-05       Impact factor: 6.447

Review 5.  Measurement of the renal clearance of drugs.

Authors:  G T Tucker
Journal:  Br J Clin Pharmacol       Date:  1981-12       Impact factor: 4.335

6.  Sequential first-pass elimination of a metabolite derived from a precursor.

Authors:  K S Pang; J R Gillette
Journal:  J Pharmacokinet Biopharm       Date:  1979-06

7.  Perinatal development of, and effect of chemical pretreatment on, glycine N-acyltransferase activities in liver and kidney of rabbit and rat.

Authors:  M O James; J R Bend
Journal:  Biochem J       Date:  1978-05-15       Impact factor: 3.857

8.  Kidney and liver contributions to salicylate metabolism in rats.

Authors:  M Láznícek; A Láznícková
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1994 Jan-Mar       Impact factor: 2.441

9.  Unlabeled aspirin as an activatable theranostic MRI agent for breast cancer.

Authors:  KowsalyaDevi Pavuluri; Ethan Yang; Vinay Ayyappan; Kanchan Sonkar; Zheqiong Tan; Caitlin M Tressler; Shaowei Bo; Adnan Bibic; Kristine Glunde; Michael T McMahon
Journal:  Theranostics       Date:  2022-01-24       Impact factor: 11.556
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.